Global Fertility Supplements Market Overview
Fertility Supplements Market Size was valued at USD 1.9 Billion in 2023. The Fertility Supplements Industry is projected to grow from USD 2.1 Billion in 2024 to USD 4.0 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.50% during the forecast period (2024 - 2032). Dropping fertility rates caused by an increase in smokers, alcohol and caffeine use, as well as an increase in smoking rates, are the key market drivers enhancing the market growth.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Fertility Supplements Market Trends
-
The rise in smokers' numbers and the consequent decline in fertility rates are fueling the market's growth
In the coming years, market expansion is anticipated to be driven by an increase in consumption of alcohol and caffeine as well as an increase in smokers, which has led to a decline in birth rates. The demand for the product has been boosted by elements such rising healthcare costs, changing lifestyles, new food innovations, and medical advancements. The market for fertility supplements is expanding globally as a result of women deferring pregnancies and ongoing fertility rate declines. The COVID-19 pandemic had a positive impact on the market for fertility supplements since it was shown that the COVID-19 virus had an impact on a person's level of fertility. According to the article "Potential Role of Zinc in the COVID-19 Disease Process and its Probable Impact on Reproduction" published in January 2021, zinc supplements can also lessen or prevent damage to egg and sperm cells caused by the body's immune response to the coronavirus. During the epidemic, this research increased consumer demand for reproductive supplements, which was advantageous for business.
In the near future, it is anticipated that the market for functional foods and beverages will develop, which might potentially impede the expansion of the whole business. Foods like olive oil, whole grains, avocados, and high-fat dairy products are increasingly used to boost fertility. Although it is anticipated that the usage of herbal (or botanical) medications would rise due to consumer concern about the unfavourable side effects of traditional pharmaceutical pharmaceuticals, this will be advantageous for product manufacturers. Consumers are now more likely to purchase supplements based on what is best for their health rather than attractive marketing and packaging thanks to a number of government programmes to promote understanding of the breakthroughs in supplement research and cutting-edge technologies.
Industry expansion is being fueled by consumers' expanding preference for infertility prevention strategies including eating a balanced diet and using more nutritional supplements. In addition, a number of ailments, including sexually transmitted infections (STDs) and conditions that impact fertility, are to blame for the rise in infertility rates. As a result, it is projected that the market for fertility supplements would expand more quickly in the near future as infertility rates rise. Recently, Argentine and Brazilian consumers have placed a strong emphasis on improving their sexual health and wellbeing. People are therefore more willing to spend money on the right things. Consequently, it is projected that throughout the upcoming years, demand for fertility pills would increase. Thus, driving the Fertility Supplements market revenue.
Fertility Supplements Market Segment Insights
Fertility Supplements Ingredient Insights
The Fertility Supplements Market segmentation, based on ingredient, includes natural and synthetic/ blend of natural & synthetic. Synthetic/ blend of natural & synthetic segment dominated the global market in 2022. Due to rising demand and simple accessibility, the main synthetic ingredients—selenium, zinc, folic acid, vitamin C, vitamin B6, CoQ1, and myo-inositol—contributed significantly to total expansion.
Fertility Supplements Product Insights
The Fertility Supplements Market segmentation, based on product, includes capsules, tablets, soft gels, powder, and liquids. The capsules segment dominated the global market in 2022. This is because there is greater knowledge of the nutritional advantages these products provide, as well as the exquisite flavours and simplicity of use in meals. These goods ensure the administration of oil- and fat-soluble nutrients, allow for novel component combinations, lessen gastrointestinal discomfort, guard against sensitive chemicals.
Fertility Supplements End Use Insights
The Fertility Supplements Market segmentation, based on end use, includes men and women. Women segment dominated the Fertility Supplements Market in 2022. The Centres for Disease Control and Prevention estimate that 19% of women between the ages of 15 and 49 who have never given birth struggle with infertility. However, married infertile women between the ages of 40 and 44 and women between the ages of 35 and 39 had the highest prevalence of fertility problems. Government and nonprofit initiatives to offer guidance and medical aid have contributed to raising awareness, creating market potential for product producers.
Fertility Supplements Distribution Channel Insights
The Fertility Supplements Market segmentation, based on distribution channel, includes OTC and prescribed. The OTC segment dominated the Fertility Supplements Market in 2022. The market is fragmented as a result of the increased demand, cheap access to raw resources, and lax regulations. Companies must focus on adding FDA-regulated components that have undergone a sizable number of clinical trials or studies if they want to compete in this fiercely competitive market. Self-medication for the treatment of infertility problems is one of the major trends in the OTC market. Additionally, it is anticipated that in the near future, manufacturers of OTC fertility supplements will benefit from features including the cost-effectiveness and ease of direct purchasing.
Figure 1: Fertility Supplements Market, by Distribution Channel, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Fertility Supplements Regional Insights
By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North America Fertility Supplements Market dominated this market in 2022 (45.80%). In the United States, 13.1% of women between the ages of 15 and 49 had impaired fertility, 14.1% of married women between the ages of 15 and 49 had impaired fertility, and 6% of married women were discovered to be infertile, according to data from the Centres for Disease Control and Prevention (CDC) December 2021 update. This increased product demand in the area. Further, the U.S. Fertility Supplements market held the largest market share, and the Canada Fertility Supplements market was the fastest growing market in the North America region.
Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2: FERTILITY SUPPLEMENTS MARKET SHARE BY REGION 2022 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe Fertility Supplements market accounted for the healthy market share in 2022. Due to the improved accessibility and availability of healthcare facilities as well as the increased spending in the research and healthcare sectors, the area presents lucrative potential for leading firms in the fertility supplement market. Further, the German Fertility Supplements market held the largest market share, and the U.K Fertility Supplements market was the fastest growing market in the European region
The Asia Pacific Fertility Supplements market is expected to register significant growth from 2023 to 2032. Rising nutritional enrichment awareness is expected to be a key driver of regional growth in both China and India. Additionally, it is anticipated that over the course of the forecast period, buyer accessibility would improve as a result of the expansion of the retail market in nations like India, China, Indonesia, and Malaysia as a result of governmental support for investment. This will aid the market expansion in the area. Moreover, China’s Fertility Supplements market held the largest market share, and the Indian Fertility Supplements market was the fastest growing market in the Asia-Pacific region.
Fertility Supplements Key Market Players & Competitive Insights
Leading market players are investing heavily in research and development in order to expand their product lines, which will help the Fertility Supplements market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their global footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Fertility Supplements industry must offer cost-effective items.
Manufacturing locally to minimize Productal costs is one of the key business tactics used by manufacturers in the global Fertility Supplements industry to benefit clients and increase the market sector. In recent years, the Fertility Supplements industry has offered some of the most significant advantages to medicine. Major players in the Fertility Supplements market, including Fairhaven Health, Coast Science, Lenus Pharma GesmbH, Active Bio Life Science GmbH, Orthomol, Exeltis USA, Inc., PregPrep LLC, Bionova, Vitabiotics Ltd., TTK Healthcare Ltd., Fertility Nutraceuticals LLC, extreme V, Inc., VH Nutrition LLC, CellOxess LLC, Gonadosan, Amino Expert (Innovamed Ltd.), Babystart Ltd., Crown Nutraceuticals, Sal Nature, and YadTech, are attempting to increase market demand by investing in research and development Products.
Manufacturer of wellness goods with a health-oriented focus is Wellbeing Nutrition. Vitamins, performance packs, hair packs, hair care kits, and other related products are among the company's food offerings, giving customers access to natural ingredients that are healthful and kept without preservatives. Wellbeing Nutrition unveiled SLOW, a range of time-conscious nutraceuticals for both men and women, in April 2022. It comprises of 13 supplements, each specifically made to address a different wellness or health requirement, such as supporting conception.
A biotechnology business called EMD Serono finds and creates biopharmaceutical products. It focuses on specialised fields like oncology, metabolic endocrinology, fertility, and neurological illnesses. The business was established in 1971, and its main office is in Rockland, Massachusetts. To advance further and expand its line of products, it looks to buy other businesses in the same industry. Slim Pack reproductive drug packaging was introduced in February 2022 by EMD Serono, a division of Merck KGaA focused on healthcare. This packaging was scaled out for convenience and environmental effect. With this launch, we hope to increase convenience, portability, and effectiveness.
Key Companies in the Fertility Supplements market include
- Fairhaven Health
- Coast Science
- Lenus Pharma GesmbH
- Active Bio Life Science GmbH
- Orthomol
- Exeltis USA, Inc.
- PregPrep LLC
- Bionova,
- Vitabiotics Ltd.
- TTK Healthcare Ltd.
- Fertility Nutraceuticals LLC
- extreme V, Inc.
- VH Nutrition LLC
- CellOxess LLC
- Gonadosan
- Amino Expert (Innovamed Ltd.)
- Babystart Ltd.
- Crown Nutraceuticals
- Sal Nature
- YadTech
Fertility Supplements Industry Developments
April 2022 Two new prenatal vitamin supplements have been introduced by the reproductive health company Ovaterra by Fertility Nutraceuticals. They are individual-serving-sized prenatal capsules that are designed to contain the entire amount of choline that is advised for pregnant and breastfeeding women.
Fertility Supplements Market Segmentation
Fertility Supplements Ingredient Outlook
- Natural
- Synthetic/ Blend of Natural & Synthetic
Fertility Supplements Product Outlook
- Capsules
- Tablets
- Soft Gels
- Powder
- Liquids
Fertility Supplements End Use Outlook
Fertility Supplements Distribution Channel Outlook
Fertility Supplements Regional Outlook
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Australia
- Rest of Asia-Pacific
- Rest of the World
- Middle East
- Africa
- Latin America
Report Attribute/Metric |
Details |
Market Size 2023 |
USD 1.9 Billion |
Market Size 2024 |
USD 2.1 Billion |
Market Size 2032 |
USD 4.0 Billion |
Compound Annual Growth Rate (CAGR) |
8.50% (2024-2032) |
Base Year |
2023 |
Market Forecast Period |
2024-2032 |
Historical Data |
2018- 2022 |
Market Forecast Units |
Value (USD Billion) |
Report Coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
Segments Covered |
Ingredient, Product, End Use, Distribution Channel, and Region |
Geographies Covered |
North America, Europe, Asia Pacific, and the Rest of the World |
Countries Covered |
The U.S., Canada, German, France, U.K, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
Key Companies Profiled |
Fairhaven Health, Coast Science, Lenus Pharma GesmbH, Active Bio Life Science GmbH, Orthomol, Exeltis USA, Inc., PregPrep LLC, Bionova, Vitabiotics Ltd., TTK Healthcare Ltd., Fertility Nutraceuticals LLC, extreme V, Inc., VH Nutrition LLC, CellOxess LLC, Gonadosan, Amino Expert (Innovamed Ltd.), Babystart Ltd., Crown Nutraceuticals, Sal Nature, and YadTech |
Key Market Opportunities |
Rising demand for natural ingredients |
Key Market Dynamics |
The declining fertility rates brought on by the rise in the number of smokers and the rising consumption of alcohol and caffeine |
Frequently Asked Questions (FAQ) :
The Fertility Supplements Market size was valued at USD 1.9 Billion in 2023.
The global market is projected to grow at a CAGR of 8.50% during the forecast period, 2024-2032.
North America had the largest share in the global market
The key players in the market are Fairhaven Health, Coast Science, Lenus Pharma GesmbH, Active Bio Life Science GmbH, Orthomol, Exeltis USA, Inc., PregPrep LLC, Bionova, Vitabiotics Ltd., TTK Healthcare Ltd., Fertility Nutraceuticals LLC, extreme V, Inc., VH Nutrition LLC, CellOxess LLC, Gonadosan, Amino Expert (Innovamed Ltd.), Babystart Ltd., Crown Nutraceuticals, Sal Nature, and YadTech
The Synthetic Ingredient dominated the market in 2022.
The Capsules Product had the largest share in the global market.